235 related articles for article (PubMed ID: 62087)
1. [Cytological diagnosis of precancerous conditions and neoplasms of the cervix uteri].
Novik VI
Lab Delo; 1976; (5):286-9. PubMed ID: 62087
[No Abstract] [Full Text] [Related]
2. [Cytological classification of precancer and cancer of the cervix uteri].
Agamova KA; Nikitina NI; Gosh TE; Tikhomirova EE; Gladunova ZD
Vopr Onkol; 1987; 33(5):54-9. PubMed ID: 3590668
[TBL] [Abstract][Full Text] [Related]
3. [Modified endocervical vaginal smear for diagnosis of endocervical microinvasive cervix carcinoma].
Melsheimer P; Hahn U; Herberling D; Wallwiener D; Rummel HH; Bastert G
Zentralbl Gynakol; 1995; 117(11):608-10. PubMed ID: 8533497
[TBL] [Abstract][Full Text] [Related]
4. Benign to malignant progression in cervical squamous epithelium.
Ehrmann RL
Compr Ther; 1996 Feb; 22(2):67-75. PubMed ID: 8689865
[No Abstract] [Full Text] [Related]
5. [Precancerous changes in the cervix uteri and endometrium].
Zheleznov BI
Arkh Patol; 1972; 34(5):3-17. PubMed ID: 4588027
[No Abstract] [Full Text] [Related]
6. Computer recognition of cell nuclei from the uterine cervix.
Bibbo M; Bartels PH; Bahr GF; Taylor J; Wied GL
Acta Cytol; 1973; 17(4):340-50. PubMed ID: 4579185
[No Abstract] [Full Text] [Related]
7. [Evaluation of cytological screening for cancers and precancerous lesions of the cervix].
Boman F; Duhamel A; Trinh QD; Deken V; Leroy JL; Beuscart R
Bull Cancer; 2003 Jul; 90(7):643-7. PubMed ID: 12957806
[TBL] [Abstract][Full Text] [Related]
8. Dysplasia, carcinoma in situ, and invasive carcinoma of the cervix uteri in previously screened women.
Hoeg K; Roger V
Scand J Clin Lab Invest Suppl; 1968; 106():173-80. PubMed ID: 5731703
[No Abstract] [Full Text] [Related]
9. [Cytological classifications of vaginal smears. Current concepts of complex cytodiagnosis].
Kasabova M
Akush Ginekol (Sofiia); 1984; 23(4):357-64. PubMed ID: 6385754
[No Abstract] [Full Text] [Related]
10. [Comparative cyto-histological studies on the precancerous and early stages of cervix carcinoma with simultaneous trichomonas vaginitis].
Boquoi E
Z Geburtshilfe Gynakol; 1968; 169(1):59-74. PubMed ID: 5678667
[No Abstract] [Full Text] [Related]
11. [Appearance of parakeratosis cells in cervical smears following hormonal therapy and its significance].
Clocuh YP
Fortschr Med; 1980 Nov; 98(41):1612-3. PubMed ID: 7203333
[TBL] [Abstract][Full Text] [Related]
12. Premalignant conditions of the cervix.
Burghardt E
Clin Obstet Gynaecol; 1976 Aug; 3(2):257-94. PubMed ID: 1009723
[No Abstract] [Full Text] [Related]
13. [Possibilities of cytologic diagnosis of uterine cervix carcinoma in situ].
Novik VI
Vopr Onkol; 1996; 42(5):109-12. PubMed ID: 9064894
[TBL] [Abstract][Full Text] [Related]
14. Non-diagnostic squamous atypia in cervico-vaginal cytology as a risk factor for early neoplasia.
Melamed MR; Flehinger BJ
Acta Cytol; 1976; 20(2):108-10. PubMed ID: 779384
[No Abstract] [Full Text] [Related]
15. [Foundations for differential cytology of cervical changes. 3. Dysplasia and carcinoma in situ (author's transl)].
Höffken H; Rummel HH
Zentralbl Gynakol; 1981; 103(24):1517-36. PubMed ID: 7340303
[TBL] [Abstract][Full Text] [Related]
16. The Bethesda System and patient management strategies.
Helmuth RA; Moriarty AT; Schwenk GR
Indiana Med; 1992; 85(6):500-3. PubMed ID: 1431035
[No Abstract] [Full Text] [Related]
17. [Morphologic and histochemical changes in the ovaries in precancerous conditions and cancer of the uterus].
Dobrynin VA; Gataullin KD
Arkh Patol; 1973; 35(8):38-41. PubMed ID: 4781611
[No Abstract] [Full Text] [Related]
18. [Morphological conditions preceding the development of cancer of the cervical canal].
Korotkikh IN
Sov Med; 1985; (12):102-3. PubMed ID: 4095618
[No Abstract] [Full Text] [Related]
19. The exfoliating cervical epithelial surface in dysplasia, carcinoma in situ and invasive squamous carcinoma. I. Scanning electron microscopic study.
Rubio CA; Kranz I
Acta Cytol; 1976; 20(2):144-50. PubMed ID: 1065174
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinoma in situ of the cervix: sensitivity of detection by cervical smear: will cytologic screening for adenocarcinoma in situ reduce incidence rates for adenocarcinoma.
Smith HO; Padilla LA
Cancer; 2002 Dec; 96(6):319-22. PubMed ID: 12478677
[No Abstract] [Full Text] [Related]
[Next] [New Search]
